Oncothermia brings new hope to cancer patients

Saudi Gazette

RIYADH — Driven by a great desire to help cancer patients and reduce their suffering, Prof. Andras Szasz, founder and head of research at Oncotherm company, has developed a painless therapy to complement cancer treatment.

Known as oncothermia, it is a modulated-electro-hyperthermia for oncological use. It is a fast developing supportive, complementary treatment method against different types of tumors. The Saudi Food and Drugs Authority recently approved the procedure.

The principles of treatment are based on the classical method of hyperthermia, but the aim, beside the absolute increase in temperature, is especially the direct electric-field energy absorption in the extracellular liquid and destroying the membrane of the cancer cells.

Oncothermia’s effect is synergic to radiotherapy and to numerous chemotherapies. Furthermore, it leads to an increased immunogenicity and effectively reduces the pain of the patient.

Saudi Gazette met with Prof. Szasz, who was on a visit to Riyadh and Jeddah recently and had multiple meetings with stakeholders about his invention and how it helps cancer patients across five continents.

“I started working on my invention since 1988. The journey was very long and it was not easy. There were many trials and errors and countless procedures to make it recognizable,” he said.

“In 2002, we started spreading my invention through my company, which is only responsible for serious medical tasks. Currently, we have spread it in 35 countries and now 200,000 oncothermia procedures are performed annually,” he added.

The invention had produced encouraging results in enhancing the survival time of cancer patients. “The cases treated by oncothermia had shown a 20 percent improvement in the quality of lives for patients. However, we cannot separate the invention from other crucial factors, such as medications and a determination for survival,” he emphasized.

The researcher said oncothermia is absolutely safe and has no side effects. “It can be used for all age groups, female and male, and all types of cancer except leukemia.

I have strong hope that Saudi hospitals will apply this method in treatment,” Szasz said.

Dr. Hamad Al-Omar, chairman of the National Blood and Cancer Center, said there were more than 20,000 new cancer cases in the Kingdom in 2017, in addition to existing patients. “The Ministry of Health is working hard to enhance services given to cancer patients. We held several talks with Prof. Szasz and we hope to adopt this new method in our public and private hospitals,” he said.

Dr. Al-Omar said the main causes of cancer in the Kingdom are smoking, lack of exercise and unhealthy diet. “However, with the new treatment methods, we can think of cancer as a chronic disease, not a fatal disease,” he stressed.

He said cancer can be fully cured while diabetes for example is incurable. “Unfortunately, people think of cancer as a fatal disease that is incurable when the truth is most cancer cases can be cured,” Al-Omar said.

He emphasized that prevention is much better than cure. “By adopting a healthy lifestyle, we can reduce the possibility of us getting diseases. If we look back 10 years, diabetes affected only 5 percent of people while today it is 30 percent, all because of the unhealthy lifestyles,” he concluded.

 

 

Board inauguration

Oncotherm Kft. is proud of its ability to contribute to strengthening the practical aspect of education. This task is performed by the Outsourcing Department of Biotechnics of Szent István University at Oncotherm Kft. in Budaörs.

Oncotherm Kft. and the Outsourcing Department of Biotechnics are cooperating in the overall harmony of the university education and the industry, especially by training the students of the doctoral school. On September 14, 2017, an information board was hanged up, the inauguration of which was brought about by the change of the site of Oncotherm Kft.

Oncotherm Kft. thanks to all members of the board promotion for their participation. The fact was particularly honored that we were able to welcome prominent professors at the inauguration, namely:

Dr. Gyula Péter Szigeti – Vice President for Research and Development of the National Research, Development and Innovation Office
Prof. Dr.János Tőzsér – Rector of Szent István University
Prof. Dr. István Szabó – Vice-Rector for International Relations of Szent István University
Prof. Dr. László Kátai –  Dean of the Faculty of Mechanical Engineering at Szent István University
Dr. Tibor Krenács – 1st Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, senior research fellow

The event was honored by the presence of two former PhD students who had already participated in the training program which began in 1994:
Prof. Dr. Gabriella Hegyi – Head of Department of the Faculty of Health Sciences Complementary Department of Medicine at Pécsi Tudományegyetem and Director of Konfucius Institute
Prof. Dr. Ibolya Zsoldos – Head of Department of Materials Science and Technology at István Széchenyi University, Deputy Assistant Dean of the Audi Hungaria Vehicle Engineering Faculty

Board inauguration was followed by the presentation of the company’s results and publications and the presentation of the departments of the company.

Internal charge redistribution and currents in cancerous lesions

Andars Szasz, Gyula Vincze, Gyula Szigeti, Oliver Szasz

ABSTRACT

The tissues in biological objects from the point of view of electromagnetic effects have to be modeled by not only their conductivity. The electric field induced double ionic layer, constructed by electrolytic diffusion, has to be counted. We describe this phenomenon by micro (frequency dispersion phenomena), and by macro (interfacial polarization), as well as more generalized by Nernst-Planck cells. The results are applied to cancerous tissues in the healthy neighborhood. Our objective is to show the space charge distribution and redistribution that generate injury currents and other internal currents in the development of cancer. We show some aspects of the theoretical basis of modulated electro-hyperthermia (mEHT, trade name oncothermia, also used name: nanothermia), which uses an anti-injury current in the micro-range to limit the proliferation process, similar to the macro-range electrochemotherapy (ECT) processes.

For detailed information please follow the link:

http://cirworld.com/index.php/jab/article/view/6328/6283

Intrinsic Noise Monitoring of Complex Systems

Oliver Szasz, Gyula Vincze, Gyula Peter Szigeti, Andras Szasz

ABSTRACT

The power-density function of the noise spectrum of open and complex systems changes by the power of frequency. We show that the fluctuation origin and the noise-powered description are equivalent to describe the colored noise power density. Based on this, we introduce a scale-independent invariant for monitoring the dynamics of the complex system. The monitoring of the noise spectrum of the system specifies the forecast of failure, the timing of desired regular corrections and/or the assessed operation life of the system, indicating the possible faults before it happens, predicting deterioration like wear/tear, fatigue in the still properly working system. These considerations are highly applicable to living systems and their preventive care.

For detailed information please follow the link:

http://file.scirp.org/Html/3-1850161_79028.htm

The 3rd International Prostate Symposium

The 3rd International Prostate Symposium carries an ambitious title: “Overcome Challenges for Future Innovation”. Accordingly, physicians and scientists present new therapies, approaches to research, but also practical reports. Prof. Dr. András Szász, head of the Department of Biotechnics, St. Istvan University, Hungary, and founder of Oncothermia is chairman of the scientific program. He introduces the topic “New Paradigm to Treat Malignant and Benign Prostate Tumors – Oncothermia”.For detailed information please follow the link:

http://www.openpr.de/news/961376.html

Dr. Szasz’s chapter has been downloaded 3000 times to date.

We are pleased to inform you that Prof. Dr. Szasz’s chapter has been downloaded 3000 times to date.

Edited by Juan Carlos Moreno-Piraján, ISBN 978-953-307-979-0, 446 pages, Publisher: InTech, Chapters published September 15, 2011 under CC BY-NC-SA 3.0 license
DOI: 10.5772/1434

BOOK TITLE: Thermodynamics – Physical Chemistry of Aqueous Systems

CHAPTER TITLE: On the Extremum Properties of Thermodynamic Steady State in Non-Linear Systems

For detailed information please follow the link:

https://www.intechopen.com/books/thermodynamics-physical-chemistry-of-aqueous-systems

 

Heating Preciosity—Trends in Modern Oncological Hyperthermia

Heating Preciosity—Trends in Modern Oncological Hyperthermia by Szasz, O., Szasz, M.A., Minnaar, C. and Szasz, A. (2017) Heating Preciosity—Trends in Modern Oncological Hyperthermia. Open Journal of Biophysics, 7, 116-144. 

ABSTRACT

The use of hyperthermia as a treatment in oncology is a common topic for debate. Some researchers expect a breakthrough in oncological treatments with hyperthermia, whereas others have disregarded the method. Serious questions concerning hyperthermia have arisen. Should homogeneous (isothermal) or heterogeneous (selective) heating being used? When we use selective heating (heterogeneity), should the entire tumour be targeted or should the malignant cells be individually selected? Does the mechanism involve thermal cell death or thermally-assisted cell death? Is the goal necrosis or apoptosis? Is hyperthermia safe as a monotherapy or does it have to be combined with conventional treatments? When the selection is local, how do we act on disseminated cells that represent a high risk of life threatening metastases? When local heating is the focus, how should it be carried out with measured and controlled? Our objective is to show how precise, selective heat transfer is necessary to remove malignant cells and, consequently, how hyperthermia as part of the immune-oncology can change the game in this promising field of oncological therapies.

For detailed information please follow the link:

https://www.scirp.org/journal/PaperInformation.aspx?PaperID=77458

Nanothermia: Cancer cells in the focus of modulated Hyperthermia

Nanothermia: Krebszellen im Fokus elektrisch modulierter Hyperthermie:

„Hyperthermie kämpft nicht nur gegen Krebs, sondern auch für mehr Lebensqualität und Lebensdauer der Patienten. “PR- Inside Press & Media Services Date: 2017.06.01. 08:34:34

Nanothermia: Cancer cells in the focus of modulated Hyperthermia

Hyperthermia does not only fight against cancer, but also for a better quality of life and a longer survival time of the patient. The Spanish magazine Diario Sur now reported about a talk of the Oncotherm founder Prof. Dr. András Szász at the Cellumed-Clinic in Marbella. In this he explained the difference between Nanothermia and Hyperthermia.

For detailed information please follow the link:

http://www.pr-inside.com/de/nanothermia-krebszellen-im-fokus-elektrisch-modulierter-hyperthermie-r4601478.htm 

Prof. Dr. Szasz’s chapter has been downloaded 500 times to date.

We are pleased to inform you that Prof. Dr. Szasz’s chapter has been downloaded 500 times to date.

Edited by: Mofid Gorji-Bandpy

ISBN 978-953-51-2239-5

Publisher: InTech

Publication date: December 2015

BOOK TITLE: Thermo and Fluid Dynamics

CHAPTER TITLE: “Nonequilibrium Thermodynamic and Quantum Model of a Damped Oscillator”

For detailed information please follow the link:

https://www.intechopen.com/books/recent-advances-in-thermo-and-fluid-dynamics/nonequilibrium-thermodynamic-and-quantum-model-of-a-damped-oscillator